ABSTRACT-Objective: Crush syndrome (CS) is a serious medical condition characterized by muscle cell damage resulting from pressure. CS has a high mortality, even when patients receive fluid therapy. We examined whether administration of NaNO 2 -containing fluid can improve survival in a rat model of CS. Design: The CS model was generated by subjecting anesthetized rats to bilateral hind limb compression with a rubber tourniquet for 5 h. Rats were then randomly divided into six groups: sham; CS with no treatment; CS with normal saline treatment; CS with normal saline þ 25 mEq/L bicarbonate treatment; and CS with normal saline þ 200 or 500 mmol/kg NaNO 2 . Measurements and Main Results: Blood and tissue samples were collected for histological and biochemical analyses at predetermined time points before and after reperfusion. Ischemic compression of rat hind limbs reduced nitrite content in the crushed muscle, and subsequent reperfusion resulted in reactive oxygen species-induced circulatory dysfunction and systemic inflammation. Rats treated with 200 mmol/kg NaNO 2 showed increased nitric oxide (NO) levels, blood circulation, and neoangiogenesis, decreased generation of reactive oxygen species, and suppression of the inflammatory response, leading to complete recovery. Conclusions: Treatment with 200 mmol/kg NaNO 2 prevents muscle damage induced by ischemia reperfusion via the protective effects of NO and suppression of systemic inflammation, thereby increasing survival rates in CS.
INTRODUCTION
Crush syndrome (CS) is a serious medical condition resulting from physical trauma obtained during events such as earthquakes, landslides, and traffic accidents, which is characterized by circulatory shock, kidney failure, and systemic inflammation (1, 2) , and is associated with high mortality rates, especially in the acute phase. CS develops after decompression of limb muscles (reperfusion) following prolonged compression (ischemia) of a large proportion of skeletal muscle, resulting in rhabdomyolysis (muscle cell breakdown). However, CS has not only local effects but can also cause systemic failure resulting from acute respiratory distress and systemic inflammatory response syndromes, multiple organ failure, and confounding late-phase symptoms (3).
Fluid therapy is the first-line treatment for CS; shock and acute kidney failure can be prevented by early provision of fluid. Electrolyte abnormalities are common in patients with crush-related acute kidney failure, with fatal hyperkalemia being the most severe case for which treatment with normal saline containing sodium bicarbonate is recommended (4) .
In addition to studies and clinical reports describing renal dysfunction caused by crushed muscle, CS can also cause a systemic inflammatory response that can lead to damage in more distant organs such as the lung (3, 5) . We previously developed a rat model of severe CS (6) and reported that effective rapid phleboclysis consisting of a single injection of sodium nitrite (NaNO 2 ) improved survival by enhancing the recovery of muscle tissue nitrite (NO 2 À ) levels and increasing myeloperoxidase (MPO) activity in both the muscle and the lung (7) . NaNO 2 is thought to enhance kidney function and reduce systemic inflammation by increasing nitric oxide (NO) recovery. However, doses of 200 mmol/kg and 500 mmol/kg can also induce vasodilation and methemoglobinemia. We hypothesized that side effects could be avoided by continuous infusion of NaNO 2 -containing fluid. Our results demonstrate that intravenous administration of NO 2 À is an effective first-line fluid therapy for treating CS.
MATERIALS AND METHODS

Animal model of CS
Male Wistar rats weighing 250 g to 300 g were obtained from Japan SLC (Shizuoka, Japan) and housed in a room maintained at a temperature of
Experimental design
Animals were randomly divided into six groups: sham; CS with no treatment (CS only group); CS with normal saline treatment (S group); CS with normal saline þ 25 mEq/L bicarbonate treatment (SB group); and CS with normal saline þ different doses of NaNO 2 salt (200 mmol/kg or 500 mmol/kg NaNO 2 ; Wako Pure Chemical Industries, Osaka, Japan) (S-200N and S-500N groups, respectively). Third to sixth groups were subjected to compression with the rubber tourniquet, followed by 3 h of reperfusion by massive fluid resuscitation at a rate of 30 mL/kg/h.
Analysis of mean arterial pressure, blood gas levels, biochemical parameters, coagulation, and nitrogen oxide and interleukin levels Mean arterial pressure (MAP) was determined using a Softron device (Softron Co, Tokyo, Japan). Blood samples from each group were obtained 1, 3, 6, and 24 h after reperfusion. The pH, partial pressure of oxygen (O 2 ) and carbon dioxide (CO 2 ), bicarbonate (HCO 3 À ) concentration, and base excess of arterial blood drawn from the femoral artery were analyzed using an i-STAT300F blood gas analyzer (FUSO Pharmaceutical Industries, Osaka, Japan). Venous blood from the post-caval vein was collected and centrifuged to measure plasma levels of potassium (K þ ), blood urea nitrogen (BUN), creatinine (Cre), and creatine phosphokinase (CPK) (measurements were carried out by SRL Inc, Tokyo, Japan). Methemoglobin (Met-Hb) was measured as previously described (7) . Platelets were measured using a Celltac hematology analyzer (Nihon Kohden Co, Tokyo, Japan), and the levels of von Willebrand factor (vWF) were measured using a rat vWF enzyme-linked immunosorbent assay (ELISA) kit (USCN, Houston, Tex). Nitrite ( 
Assessment of kidney function
The bladder was cannulated in parallel to the jugular vein with PE-50 tubing. Urine samples were obtained from 1 h prior to decompression until immediately after decompression (0 h). Urine samples were collected every hour for 24 h and centrifuged at 1,500 Â g for 5 min at room temperature. Kidney function was determined based on glomerular filtration rate (GFR), urine volume, urine osmotic pressure (Osmomat 030-D; Gonotec GmbH, Berlin, Germany), Nacetyl-b-D-glucosaminidase (NAG) level (Shionogi and Co, Osaka, Japan), and urine pH (Pretest 5bII; Wako Pure Chemical Industries).
Determination of reactive oxygen species production and MPO activity
Reactive oxygen species (ROS) production in the injured gastrocnemius muscle was determined by measuring the concentration of thiobarbituric acidreactive substances (TBARS). MPO activity in the muscle tissue was measured as previously described (6) . For histological evaluations, tissue samples were fixed in 10% formalin and embedded in paraffin, and sections were cut and stained with hematoxylin and eosin, elastic Van Gieson, and anti-vWF antibody (Agilent Technologies, Santa Clara, Calif). Microphotographs of the tissue sections were then evaluated by a pathologist (New Histo Science Laboratory, Tokyo, Japan). Blood was removed from the sampled tissues by the continuous infusion of phosphate buffer solution through the heart.
Western blotting
Western blotting was carried out as previously described (8) . Briefly, rat muscle tissue was homogenized and centrifuged, and proteins in the lysate were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis using antibodies against inducible NO synthase (iNOS; Cell Signaling Technology, Tokyo, Japan), heme oxygenase (HO)-1 (Thermo Fisher Scientific K.K., Kanagawa, Japan), and a-tubulin (Cell Signaling Technology). Protein bands were visualized with an enhanced chemiluminescence detection system (SuperSignal West Dura Extended Duration Substrate; Pierce Biotechnology) with horseradish peroxidase-conjugated secondary antibodies (Pierce Biotechnology). Band intensity was quantified using ChemiDoc XRSþ Molecular Imager with Image Lab software (Bio-Rad Laboratories, Hercules, Calif), with atubulin used as a loading control.
Survival analysis
To assess relative survival, animals were randomly assigned to five groups corresponding to the treatment regimens described above: sham (n ¼ 10), CS only (n ¼ 20), S (n ¼ 10), SB (n ¼ 10), and S-200N (n ¼ 10). The survival rate in each group was recorded 3, 6, 24, and 48 h after reperfusion.
Statistical analysis
Results are the average of three independent experiments and are expressed as mean AE SEM. Differences between groups were assessed by analysis of variance, with post-hoc analysis using Tukey Honest Significant Difference test (also known as Tukey test). Survival curves were generated using the KaplanMeier method, and survival was compared with the log-rank test. Differences were considered significant for P values <0.05.
RESULTS
NaNO 2 treatment improves Met-Hb and blood gas levels and MAP
NO 2
À is reduced to NO in vivo; NO accumulation can lead to methemoglobinemia and reduced blood pressure. We measured the effect of NaNO 2 concentration (200 mmol/kg and 500 mmol/kg) on Met-Hb and blood gas levels and MAP in CS rats until reperfusion at 24 h.
During fluid resuscitation, MAP was similar between the S-500N and CS only groups; however, there was no change in MAP in the S-200N group throughout the experiment (Supplemental Digital Content Table 1 http://links.lww.com/SHK/ A521). Blood gas parameters relative to the CS only group were improved in the S-200N and S-500N groups, but were largely unchanged in the S group (Supplemental Digital Content Tables 2 and 3 , http://links.lww.com/SHK/A521). Oxygen saturation was within the normal range in all experimental groups (data not shown). Thus, treatment with 500 mmol/kg NaNO 2 increased Met-Hb, decreased MAP, and negatively affected blood gas parameters. We therefore excluded the S-500N group in subsequent experiments.
NaNO 2 treatment improves kidney function in CS
Plasma Cre and BUN levels were higher in the CS only as compared with the sham group, but were lower in the S-200N than in the CS only group after 3 and 24 h of reperfusion (Fig. 1,  A and B) . GFR as well as urine volume and osmolality were lower in the CS only than in the sham group, but were higher in the SB and S-200N groups than in the CS only and S groups (Fig. 1, C-E) . NAG level in the distal convoluted tubule was higher in the CS only group than in the sham group, and was reduced by S-200N treatment relative to the CS only group (Fig. 1F) .
Acute kidney injury in CS is characterized by acute tubular necrosis, formation of a myoglobin cast, and dilation of distal convoluted tubules followed by myoglobinuric nephropathy. The CS only and S groups showed moderate pathological dilation of distal convoluted tubules; this was improved in the SB and S-200N groups after 24 h of reperfusion (Fig. 1G) . Myoglobinuric kidney failure in CS develops as a result of myoglobinuria as well as low urine pH. Here, we found that urine pH was lower in the CS only than in the sham group after 24 h of reperfusion (6.0 AE 0.0 vs. 5.0 AE 0.0; P <0.05), whereas the S and CS only groups showed identical values (5.0 AE 0.0 vs. 5.0 AE 0.0). However, pH was increased in the SB and S-200N groups relative to the CS only group (6.0 AE 0.0 and 6.5 AE 0.2 vs. 5.0 AE 0.0, respectively; P <0.05).
Muscle tissue injury is reversed by NaNO 2 treatment NO 2 À concentrations in injured muscle were lower in the CS only, S, and SB groups after 3 h of reperfusion, but higher after 24 h of reperfusion, than in the sham group (Fig. 2A) . Conversely, NO 3 À concentrations in injured muscle were higher in the CS only and S-200N groups after 3 h of reperfusion, but lower after 24 h of reperfusion, than in the sham group (Fig. 2B) . Moreover, TBARS, MPO activity, and iNOS and HO-1 expression were increased in the CS only and S groups relative to the sham group (Fig. 2, C-F) . The CS only group had higher plasma CPK, K þ , NO 2 À , and NO 3 À levels than the sham group, indicating hyperkalemia leading to muscle cell destruction (Supplemental Digital Content Figure  1A , B, http://links. lww.com/SHK/A527). The CS only group showed moderate edema and neutrophil infiltration into injured muscle as compared with the sham group (data not shown).
NO 2 À concentrations in injured muscles were similar in the S-200N and sham groups (Fig. 2A) . However, plasma NO 2 À concentrations were significantly higher in the S-200N group Figure 1C , D, http://links.lww.com/SHK/ A527). TBARS, MPO activity, and iNOS and HO-1 expression were lower in the sham and S-200N groups than in the CS only group, but comparable levels were seen in the CS only group and the S and SB groups (Fig. 2) . Fluid resuscitation (S, SB, and S-200N groups) worsened edema relative to the sham and CS only groups after 3 h of reperfusion, resulting in moderate edema; however, the degree of edema was similar in the S-200N and sham groups at 24 h (Supplemental Digital Content Figure 2A , B, http://links.lww.com/SHK/A520). Moreover, neutrophil infiltration was reduced in the S-200N as compared with the CS only, S, and SB groups at 24 h (Supplemental Digital Content Figure 2B , http://links. lww.com/SHK/A520). We observed that vascular endothelial cell staining in the S-200N group was more prominent than in the CS only group (Supplemental Digital Content Figure 2D , http://links.lww.com/SHK/A520).
Lung tissue injury in CS is mitigated by NaNO 2 treatment
There were no pathological changes in any of the experimental groups after reperfusion for 3 h; however, the CS only group showed moderate alveolar edema and neutrophil infiltration at 24 h (Fig. 3A) , which was associated with an increase in lung tissue MPO activity (Fig. 3B) . S-200N treatment reduced the area of damage and degree of injury to the alveolar lumen structure as well as alveolar hemorrhage compared with the CS only group after 24 h of reperfusion (Fig. 3A) , with a corresponding reduction in lung tissue MPO activity (Fig. 3B) . Additionally, plasma concentrations of the proinflammatory cytokines IL-6 and -10 were higher in the CS only as compared with the sham group at 3 and 24 h of reperfusion (Fig. 3, C and D) .
NaNO 2 treatment mitigates endothelial damage and coagulation
Levels of plasma vWF, platelets, and fibrinogen were measured to assess endothelial damage and coagulation resulting from crush injury (Fig. 4) . Plasma vWF level was higher in the CS only as compared with the sham group, whereas levels were lower in the S-200N than in the CS only, S, and SB groups ( Fig. 4A) . Levels of both plasma platelets and fibrinogen were lower after 24 h in the CS only group relative to the sham group; however, this trend was reversed by fluid resuscitation (Fig. 4 , B and C).
NaNO 2 treatment increases survival rates after CS
As expected, 100% of the mice in the sham group survived for at least 48 h after reperfusion. The survival rate of rats in the CS only group decreased over time to 85%, 55%, 35%, and 35% at 3, 6, 24, and 48 h after reperfusion, respectively. A similar trend was observed in the S group. The SB group showed a higher survival rate than the CS and S groups up to 48 h after reperfusion. Unexpectedly, NaNO 2 treatment resulted in a 100% survival rate over the 48 h experimental period in the S-200N group (Fig. 5) .
DISCUSSION
Up to 20% of deaths after major earthquakes occur shortly after extrication (9) and are usually due to crush injury; this can be aggravated by extra-renal complications (infections or pulmonary, cardiovascular, hematological, gastrointestinal, neurological, or psychiatric problems), which can increase morbidity and mortality (10, 11) . On-site CS therapy can improve the probability of survival; it is recommended that normal saline (1,000 mL/h for adults) be administered to prevent acute kidney malfunction. In this study, we administered fluid at a rate of 30 mL/kg/h to examine the effect of NaNO 2 on survival rate, followed by rates of 10 mL/kg/h, 20 mL/kg/h, and 30 mL/kg/h.
The optimal dosage of NO 2 À required for a protective effect was 48 mmol to 480 mmol (in tissue) or 10 nM to 200 nM (in blood) (12) . Previous studies reported dosages of 10 mM or 50 mM and 0.2 mmol/min/kg (13, 14) . We found that 500 mmol NaNO 2 could negatively affect CS symptoms. In contrast, a dosage of 200 mmol NaNO 2 (given to the S-200N group) was within the NO 2 À concentration range in injured muscle tissue (47 AE 21 to 56 AE 21 nmol/g tissue, Fig. 2A ) and plasma (5.1 AE 5.4 to 29.2 AE 30.9 mM, Supplemental Digital Content Figure 1C , http://links.lww.com/SHK/A527) at 3 and 24 h, and did not have adverse effects.
Renal failure is a serious complication of CS that can result from circulatory shock, renal afferent arteriolar vasoconstriction (urinary concentration), increased urinary myoglobin levels, or metabolic acidosis (urinary acidity) (15) (16) (17) , all of which can cause precipitation in distal convoluted tubules and tubular cast formation with subsequent tubular obstruction. Myoglobin accumulation has also been shown to cause oxidant injury (18, 19) . In these cases, renal replacement therapy can improve patient survival.
Normal and bicarbonate-containing saline are recommended as fluids for preventing hyperkalemia and circulatory shock associated with CS. Moreover, maintaining urinary pH above 6.5 can prevent intratubular deposition of myoglobin (20) . NO has been shown to increase urinary flow (21) . In the present study, the S-200N group showed an improvement in GFR and urinary pH and volume relative to the CS only group, indicating that treatment with 200 mmol/kg NaNO 2 protected against renal failure in CS. Interestingly, NAG level in renal tubules, a marker of cytotoxicity, was normalized in the S-200N as compared with the CS only group. NO is a free radical scavenger that binds strongly to iron in hemoglobin and myoglobin. Moreover, Kanner et al. (22) reported than NO prevented the initiation of lipid peroxidation by ROS and myoglobin. The NO 2 À concentration administered in this study was higher than endogenous levels; it is possible that NO 2 À -derived NO suppressed free radicals bound to myoglobin in urine.
The principal findings of this study are that resuscitation from CS using NaNO 2 -containing fluid can improve systemic and microvascular hemodynamics. The importance of exogenous NO 2 À administration under anemic, hypoxic, and hypovolemic conditions is evidenced by the resultant decrease in vascular resistance and increase in perivascular perfusion. Restoration of blood pressure with incomplete recovery of perfusion after resuscitation prevents microvascular collapse. Low-dose NO 2 À supplementation after fluid resuscitation improved microvascular perfusion via peripheral vasodilation without decreasing blood pressure. NO production was demonstrated by the decrease in NO 2 À concentration in the early phase of reperfusion in injured muscle. Under ischemic (lowoxygen) conditions, mitochondrial dysfunction results in ROS generation. NO protects mitochondria by acting as an oxygen radical scavenger (23) . Furthermore, NO promotes antioxidation through the induction of superoxide dismutase (24) . HO-1 induction is known to be protective following injury, however in this study, while HO-1 expression was higher in the CS only group than in the sham control group; it was significantly reduced by S-200N treatment. This suggests that nitrite-containing fluid resuscitation prevented oxidative damage and thus the induction of HO-1, and therefore offers protection independently of HO-1 expression. The overall protection provided by NO 2 À (i.e., hypoxia-induced mitochondrial ROS production and blood coagulation) depends on soluble guanylyl cyclase signaling (25, 26) . NO is an important regulatory factor that inhibits leukocyte adhesion (27) , expression of intercellular adhesion molecule and p-selectin (28) , and plasma vWF levels (5). We propose that NO may prevent excessive damage resulting from inflammation and promote the recovery of muscle cells following crush injury.
Interestingly, fluid containing NaNO 2 induced neoangiogenesis and does not increase red blood cell (RBC) counts after crush injury. The decrease in blood circulation stimulated RBC production, as indicated by hematocrit level in the CS only group, which increased after 24 h of reperfusion. However, administration of NaNO 2 -containing fluid produced similar results to those observed in the sham group. NaNO 2 is a highly stable compound that releases NO only under conditions of ischemia, hypoxia, or low pH; as such, cardiovascular therapy with NO 2 À could be targeted to ischemic or hypoxic tissues, thereby reducing the risk of systemic hypotension (29) . Exogenous NO 2 À can increase perfusion when administered after fluid resuscitation following hemorrhagic shock, underscoring its potential as a therapeutic agent (30, 31) . During the stanching process, the injured vascular endothelial cells produce vWF, causing them to interact with platelets. Using # P <0.05 vs. sham group; * P <0.05 vs. CS only group; †P <0.05 vs. S group. Survival curves were generated by the Kaplan-Meier method and compared using the log-rank test. CS indicates crush syndrome.
immunostaining to detect and visualize vWF, and thus the vascular endothelial cell network, the degree of neoangiogenesis can be evaluated. We observed that the vascular endothelial damage seen in the S-200N group was less pronounced than in the CS only group (Supplemental Digital Content Figure 2D , http://links.lww.com/SHK/A520). We suggest that increasing endogenous NO enhances not only oxygen delivery but also the induction of neoangiogenesis, while decreasing shear stress via a modest vasodilatory effect (32-34) (Supplemental Digital Content Table 5 , http://links.lww.com/SHK/A521 and Fig. 2 ).
In conclusion, administration of NaNO 2 can lead to a dramatic improvement in survival following CS owing to the anti-oxidative, anticoagulant, and anti-inflammatory effects of NO 2 À acting as a NO donor in hypoxic/acidified organs.
